This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A polygenic risk score for multiple myeloma risk prediction
European Journal of Human Genetics Open Access 30 November 2021
-
Genetically determined telomere length and multiple myeloma risk and outcome
Blood Cancer Journal Open Access 14 April 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 (Internet). 2010 (cited; available from: http://globocan.iarc.fr).
Landgren O, Weiss BM . Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia 2009; 23: 1691–1697.
Hayden PJ, Tewari P, Morris DW, Staines A, Crowley D, Nieters A et al. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma. Hum Mol Genet 2007; 16: 3117–3127.
Zintzaras E, Giannouli S, Rodopoulou P, Voulgarelis M . The role of MTHFR gene in multiple myeloma. J Hum Genet 2008; 53: 499–507.
Singh MS, Michael M . Role of xenobiotic metabolic enzymes in cancer epidemiology. Methods Mol Biol 2009; 472: 243–264.
Tang L, Bergevoet SM, Gilissen C, de Witte T, Jansen JH, van der Reijden BA et al. Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells. BMC Pharmacol 2010; 10: 12.
Landgren O, Kyle RA, Hoppin JA, Beane Freeman LE, Cerhan JR, Katzmann JA et al. Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study. Blood 2009; 113: 6386–6391.
Lope V, Perez-Gomez B, Aragones N, Lopez-Abente G, Gustavsson P, Plato N et al. Occupation, exposure to chemicals, sensitizing agents, and risk of multiple myeloma in Sweden. Cancer Epidemiol Biomarkers Prev 2008; 17: 3123–3127.
Leal-Ugarte E, Gutierrez-Angulo M, Macias-Gomez NM, Peralta-Leal V, Duran-Gonzalez J, De La Luz Ayala-Madrigal M et al. MDR1 C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individuals. Hum Biol 2008; 80: 449–455.
Urayama KY, Wiencke JK, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL . MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2007; 16: 1172–1177.
Jamroziak K, Balcerczak E, Calka K, Piaskowski S, Urbanska-Rys H, Salagacka A et al. Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma. Leuk Res 2009; 33: 332–335.
Krupoves A, Seidman EG, Mack D, Israel D, Morgan K, Lambrette P et al. Associations between ABCB1/MDR1 gene polymorphisms and Crohn′s disease: a gene-wide study in a pediatric population. Inflamm Bowel Dis 2009; 15: 900–908.
Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006; 34(Web Server issue): W635–641.
Lecuyer E, Hoang T . SCL: from the origin of hematopoiesis to stem cells and leukemia. Exp Hematol 2004; 32: 11–24.
Palii CG, Perez-Iratxeta C, Yao Z, Cao Y, Dai F, Davison J et al. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. EMBO J 2010; 30: 494–509.
Acknowledgements
We acknowledge support by the recruiting hospitals and physicians of the study regions as well as their collaborating nurses and technicians. We thank Dr Fabienne Lesueur (IARC, Lyon, France) for the collection on French controls and Dr Victor Moreno (IDBELL, Barcelona, Spain) for the recruitment of Spanish controls. We thank Prof. Bugert at the Institute of Transfusion Medicine and Immunology, German Red Cross Blood Service Baden-Württemberg-Hessen for providing German control DNA samples. This work was partially supported by the grants P08-CVI-4116 from the Consejería de Salud de la Junta de Andalucia (Sevilla, Spain), PI081051 from the Fondo de Investigaciones Sanitarias (Madrid, Spain) and NN402178334 from the Polish Ministry of Science and Higher Education (Lodz, Poland).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Martino, A., Campa, D., Buda, G. et al. Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case–control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium. Leukemia 26, 1419–1422 (2012). https://doi.org/10.1038/leu.2011.352
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.352
This article is cited by
-
Study of Breast Cancer Resistance Protein ABCG2 C421A Single Nucleotide Polymorphism RS2231142 in Multiple Myeloma
Indian Journal of Hematology and Blood Transfusion (2022)
-
A polygenic risk score for multiple myeloma risk prediction
European Journal of Human Genetics (2022)
-
Genetically determined telomere length and multiple myeloma risk and outcome
Blood Cancer Journal (2021)
-
Genetic predisposition for multiple myeloma
Leukemia (2020)
-
Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case–control study in the context of the IMMEnSE consortium
Journal of Human Genetics (2013)